Literature DB >> 32200504

Mechanism of inositol-requiring enzyme 1-alpha inhibition in endoplasmic reticulum stress and apoptosis in ovarian cancer cells.

Shekufe Rezghi Barez1, Ahmad Movahedian Atar1, Mahmoud Aghaei2.   

Abstract

IRE1α endonuclease is a key regulator of endoplasmic reticulum (ER) stress that controls cell survival/apoptosis in cancers. Inhibition of IRE1α endonuclease leads to decreased splice XBP1 which decreases cell proliferation and increases cell death in cancer cells. Therefore, this study investigated the effects and mechanism of STF-083010 (an IRE1α inhibitor) on the cell growth/apoptosis of ovarian malignant cells via the XBP1-CHOP-Bim pathway following the induction of ER stress (ERS). ERS in OVCAR3 and SKOV3 cells was measured using Thioflavin T staining. The expression of ER stress response genes was evaluated by QRT-PCR. The levels of XBP1(s), PERK, phospho-PERK, p-PP2A, ATF4, BIP/GRP78, CHOP, and Bim proteins were evaluated using western blotting. Cell viability and apoptosis in STF-083010 and Tunicamycin (Tm) co-treated cells were assessed using BrdU, MTT, Annexin V-FITC/PI staining, and caspases-12 and -3 activity assays. The results showed increased XBP1, CHOP, and ATF-4 mRNA expression levels as well as high protein aggregation in STF-083010 and Tm co-treated cells. The IRE1α inhibitor down-regulated sXBP1 and BIP proteins, while XBP-1, p-PERK, ATF-4, CHOP, and Bim proteins were up-regulated. STF-083010 reduced cell proliferation and induced apoptosis through the activation of caspases-12 and -3 and Bax/Bcl-2 protein expression. In summary, the present data revealed the effects of STF-083010 in ER stress and apoptosis as well as signaling via XBP1/CHOP/Bim mediators. Thus, STF-083010 is proposed as a new target for the control of ERS in ovarian cancer cells.

Entities:  

Keywords:  Apoptosis; ER stress; IRE1α; Ovarian cancer

Year:  2020        PMID: 32200504     DOI: 10.1007/s12079-020-00562-7

Source DB:  PubMed          Journal:  J Cell Commun Signal        ISSN: 1873-9601            Impact factor:   5.782


  6 in total

1.  lncRNA NEAT1 regulates gastric carcinoma cell proliferation, invasion and apoptosis via the miR‑500a‑3p/XBP‑1 axis.

Authors:  Yun Zhou; Zhenghong Sha; Yong Yang; Shuimei Wu; Hong Chen
Journal:  Mol Med Rep       Date:  2021-05-13       Impact factor: 2.952

Review 2.  Endoplasmic Reticulum Stress in Diabetic Nephrology: Regulation, Pathological Role, and Therapeutic Potential.

Authors:  Lihua Ni; Cheng Yuan; Xiaoyan Wu
Journal:  Oxid Med Cell Longev       Date:  2021-08-02       Impact factor: 6.543

3.  Roles and Clinical Significances of ATF6, EMC6, and APAF1 in Prognosis of Pancreatic Cancer.

Authors:  Wang Xiao; Rong-Chang Cao; Wan-Jun Yang; Jie-Hui Tan; Ruo-Qi Liu; He-Ping Kan; Lei Zhou; Na Zhang; Zhi-Ye Chen; Xue-Mei Chen; Jia Xu; Guo-Wei Zhang; Peng Shen
Journal:  Front Genet       Date:  2022-02-11       Impact factor: 4.599

4.  Activation of autophagy reverses progressive and deleterious protein aggregation in PRPF31 patient-induced pluripotent stem cell-derived retinal pigment epithelium cells.

Authors:  Maria Georgiou; Chunbo Yang; Robert Atkinson; Kuan-Ting Pan; Adriana Buskin; Marina Moya Molina; Joseph Collin; Jumana Al-Aama; Franziska Goertler; Sebastian E J Ludwig; Tracey Davey; Reinhard Lührmann; Sushma Nagaraja-Grellscheid; Colin A Johnson; Robin Ali; Lyle Armstrong; Viktor Korolchuk; Henning Urlaub; Sina Mozaffari-Jovin; Majlinda Lako
Journal:  Clin Transl Med       Date:  2022-03

5.  Targeting c-Myc Unbalances UPR towards Cell Death and Impairs DDR in Lymphoma and Multiple Myeloma Cells.

Authors:  Andrea Arena; Maria Anele Romeo; Rossella Benedetti; Maria Saveria Gilardini Montani; Mara Cirone
Journal:  Biomedicines       Date:  2022-03-22

6.  Manipulation of the unfolded protein response: A pharmacological strategy against coronavirus infection.

Authors:  Liliana Echavarría-Consuegra; Georgia M Cook; Idoia Busnadiego; Charlotte Lefèvre; Sarah Keep; Katherine Brown; Nicole Doyle; Giulia Dowgier; Krzysztof Franaszek; Nathan A Moore; Stuart G Siddell; Erica Bickerton; Benjamin G Hale; Andrew E Firth; Ian Brierley; Nerea Irigoyen
Journal:  PLoS Pathog       Date:  2021-06-17       Impact factor: 6.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.